ASX:BB1Health Care Equipment & ServicesHealth Care Technology
BlinkLab Ltd
$0.690
$0.025 (3.50%)
Day Range
$0.680 – $0.735
52 Week Range
$0.435 – $1.105
Volume
130.06K
Avg Volume (10D)
203.85K
Market Cap
$105.75M
Price Chart
Market Statistics
Open$0.735
Previous Close$0.715
Day High$0.735
Day Low$0.680
52 Week High$1.105
52 Week Low$0.435
Valuation
Market Cap105.75M
Shares Outstanding153.26M
Price to Book15.29
Trading Activity
Volume130.06K
Value Traded90.47K
Bid$0.680 × 18,183
Ask$0.700 × 15,000
Performance
1 Day-2.72%
5 Day2.14%
13 Week12.60%
52 Week66.28%
YTD-11.73%
Technical Indicators
RSI (14)56.53
50-Day SMA$0.637
200-Day SMA$0.766
Latest News
Biotechnology
BlinkLab Reports Positive ADHD Assessment Results from European Dx2 Diagnostic Platform Study
BlinkLab reports ADHD Dx2 results: 82% sensitivity, 83% specificity in European study, signaling new smartphone-based diagnostic tool.
Biotechnology
BlinkLab Raises A$17.5m to Fund FDA Autism Diagnostic Clearance and Advance ADHD Trials
BlinkLab raises oversubscribed A$17.5m to push FDA autism Dx1 clearance and start ADHD Dx2 trials; Morocco rollout underpins real-world data.
Biotechnology
BlinkLab Commences Pivotal FDA 510(k) Validation Program with First Participant Enrolment
BlinkLab kicks off pivotal FDA 510(k) validation for Dx1 autism diagnostic aid; first participant enrolled as an 8-month study targeting end-2026 submission.
Biotechnology
BlinkLab Completes Pivotal FDA Study Site Network Ahead of Q1 2026 Trial Start
BlinkLab completes 10-site pivotal FDA study network ahead of March 2026 start; pilot 83.7%/84.7%; 510(k) submission H2 CY2026.